日本产埃索美拉唑价格

The main component of esomeprazole is esomeprazole magnesium. The drug reduces gastric acid secretion through a specific targeting mechanism. It is concentrated in the high-acid environment of parietal cell acid secretion microtubules and converted into an active form, thereby inhibiting H+/K+-ATPase (proton pump), inhibiting both basal gastric acid secretion and stimulated gastric acid secretion.

1. Esomeprazole is suitable for gastroesophageal reflux disease (GERD):

Treatment of erosive reflux esophagitis;

Long-term maintenance treatment to prevent recurrence of cured esophagitis patients;

Symptom control of gastroesophageal reflux disease (GERD).

2. Esomeprazole is suitable for use in combination with appropriate antibacterial therapy to eradicate Helicobacter pylori and heal duodenal ulcers related to Helicobacter pylori infection; to prevent the recurrence of peptic ulcers related to Helicobacter pylori infection.

What is the price of esomeprazole produced in Japan?

Price of esomeprazole: According to Medical Companion Travel, the Japanese version of esomeprazole is about 1,900, and the Indian version is about 500. Since exchange rates fluctuate and prices are not fixed, please consult Medical Travel for specific prices.

Precautions when using esomeprazole:

1. When any alarm symptoms occur (such as significant unintentional weight loss, repeated vomiting, dysphagia, vomiting blood or melena), when gastric ulcer is suspected or gastric ulcer is already present, malignant tumors should be excluded, because treatment with esomeprazole magnesium enteric-coated tablets can reduce symptoms and delay diagnosis.

2. Patients who have been treated with this drug for a long time (especially those who have used it for more than 1 year) should be monitored regularly.

3. When esomeprazole is used for the eradication treatment of Helicobacter pylori, possible drug interactions of all components of the triple therapy should be considered. Clarithromycin is a potent inhibitor of CYP 3A4, so the contraindications and interactions of clarithromycin should be considered when patients on triple therapy are concurrently taking other drugs that are also metabolized by CYP 3A4, such as cisapride.